Curated News
By: NewsRamp Editorial Staff
March 10, 2026
B2i Digital Spotlights Life Sciences Investor Forum with 16+ Companies
TLDR
- B2i Digital's Life Sciences Virtual Investor Forum offers investors direct access to management teams from 16 companies, providing early insights into emerging healthcare innovations.
- The forum connects public life sciences companies with global investors through scheduled live presentations, real-time Q&A sessions, and one-on-one meetings via the VIC platform.
- By facilitating investment in life sciences companies, this forum supports medical innovation that could lead to new treatments and improved healthcare outcomes worldwide.
- Discover 16 diverse life sciences companies presenting over two days, from Jupiter Neurosciences to EMVision Medical Devices, all accessible through interactive virtual sessions.
Impact - Why it Matters
This news matters because it highlights a critical bridge between life sciences innovation and investment capital, a sector driving advancements in healthcare and therapeutics. For investors, it offers direct access to executive teams from emerging companies, enabling informed decisions in a high-growth industry. For the companies, it provides a platform to showcase breakthroughs and secure funding, potentially accelerating drug development and medical device innovations. In an era where virtual engagement is key, such forums democratize investment opportunities, fostering transparency and collaboration that can lead to breakthroughs in treating diseases and improving patient outcomes, ultimately impacting global health and economic growth.
Summary
B2i Digital, Inc. is spotlighting the upcoming Life Sciences Virtual Investor Forum scheduled for March 11-12, 2026, as part of its Featured Conference program. This digital event, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, connects public life sciences companies with a global audience of individual and institutional investors through live executive presentations, real-time Q&A sessions, and one-on-one meetings. B2i Digital serves as the Official Marketing Partner, leveraging digital marketing and social media promotion to drive awareness, while the VIC platform facilitates interactive engagement and extends visibility through on-demand replays after the live sessions.
The forum features a diverse lineup of presenting companies across therapeutic and healthcare markets, including SeaStar Medical Holding Corporation, Nasus Pharma Ltd., Tonix Pharmaceuticals Holding Corp., Jupiter Neurosciences, Inc., Bora Pharmaceuticals, Prostatype Genomics AB, MetaVia Inc., Phio Pharmaceuticals Corp., Avicanna Inc., EMVision Medical Devices Ltd., Aethlon Medical, Dyadic International, Jaguar Health, Inc., Beyond Air, Inc., Cadrenal Therapeutics, Inc., and Amplia Therapeutics Ltd. Among these, Jupiter Neurosciences, Inc. and Phio Pharmaceuticals Corp. are highlighted as B2i Digital Featured Companies, showcasing innovative approaches in neuroscience and pharmaceutical development. For comprehensive details and registration, interested parties can visit the official event page on www.newmediawire.com, which provides access to company profiles and scheduling information.
Virtual Investor Conferences, a property of OTC Markets Group Inc., enables participation from companies listed on major exchanges like NYSE, Nasdaq, TSX, CSE, ASX, and OTC Markets, ensuring a broad and credible platform. B2i Digital, founded in 2021 by former Maxim Group executive David Shapiro, operates as The Capital Markets Matchmaker™, connecting investors and companies through its proprietary network of over 1.5 million market participants. This event exemplifies its "From Marketing to Meetings™" mantra, integrating digital outreach with direct investor engagement to foster capital market opportunities in the dynamic life sciences sector.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, B2i Digital Spotlights Life Sciences Investor Forum with 16+ Companies
